Novel radiopharmaceuticals and chelating agents useful in their

Details Novel radiopharmaceuticals and chelating agents useful in their Novel radiopharmaceuticals and chelating agents useful in their

1987-08-21

1990-10-16

Maples, John S.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

546290, 546294, 546295, 546296, 546298, 546299, 546300, 546314, 546316, 546318, 546321, 546323, 546326, 546328, 546334, 546335, 546336, 424 11, C07D21182, C07D21184, C07D21190, C07D21170

Patent

active

049636820

ABSTRACT:
A dihydropyridine.rarw..fwdarw. pyridinium salt type of redox, or chemical, delivery system for the site-specific and/or site-enhanced delivery of a radionuclide to the brain is provided. A chelating agent capable of chelating with a radionuclide and having a primary, secondary or tertiary amino function can be converted to the corresponding analogue in which said function is replaced with a dihydropyridine.rarw. .fwdarw. pyridinium salt redox system and then complexed with a radionuclide to provide a new radiopharmaceutical that, in its lipoidal dihydropyridine form, penetrates the blood-brain barrier ("BBB") and allows increased levels of radionuclide concentration in the brain, particularly since oxidation of the dihydropyridine moiety in vivo to the ionic pyridinium salt retards elimination from the brain while elimination from the general circulation is accelerated.
This radionuclide delivery system is well suited for use in scintigraphy and similar radiographic techniques.

REFERENCES:
patent: 4771059 (1988-09-01), Bodor

Affiliated with

Also associated with

Rating

Novel radiopharmaceuticals and chelating agents useful in their does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel radiopharmaceuticals and chelating agents useful in their , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel radiopharmaceuticals and chelating agents useful in their will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-850758